133 related articles for article (PubMed ID: 1481105)
21. [Experiences with the treatment of peripheral vascular diseases with Xavin].
Brücknerová O
Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
[No Abstract] [Full Text] [Related]
22. [Claudicatio intermittens. Is an orally administered blood extract (Actihaemyl) therapeutically effective? A multicenter study].
Liebau H
Med Welt; 1979 Sep; 30(37):1370-3. PubMed ID: 502815
[No Abstract] [Full Text] [Related]
23. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
[TBL] [Abstract][Full Text] [Related]
24. Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV. German society of Angiology.
Heidrich H; Allenberg J; Cachovan M; Creutzig A; Diehm C; Gruss J; Kriessmann A; Rieger H; Rudofsky G; Trampisch HJ
Vasa; 1992; 21(4):333-43. PubMed ID: 1485465
[No Abstract] [Full Text] [Related]
25. [Conservative therapy of arterial occlusive diseases. Double-blind study on the effect of butalamine hydrochloride].
Seboldt H
Fortschr Med; 1980 Feb; 98(7):257-60. PubMed ID: 6767648
[TBL] [Abstract][Full Text] [Related]
26. [Medical therapy of chronic obstructive arteriopathy of the lower extremities. A controlled clinical study of suloctidil versus xanthinol].
Spinella G; Majorana M
Clin Ter; 1983 Mar; 104(5):375-81. PubMed ID: 6303677
[No Abstract] [Full Text] [Related]
27. [Evaluation of cutaneous necrosis risk in peripheral arterial diseases].
D'Eri A; Martini R; Cordova RM; Trevisan G; Andreozzi GM
Minerva Cardioangiol; 2002 Jun; 50(3):239-44. PubMed ID: 12107403
[TBL] [Abstract][Full Text] [Related]
28. [Intermittent claudication treated with pentoxifylline. A controlled trial].
Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
[No Abstract] [Full Text] [Related]
29. [Naftidrofuryl in the therapy of chronic arterial occlusive disease in the intermittent claudication stage].
Valentin A; Karnik R; Stöllberger C; Slany J
Vasa Suppl; 1987; 20():361-4. PubMed ID: 3321493
[No Abstract] [Full Text] [Related]
30. [Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
Scheffler P; Birkel L; Grub KR; de la Hamette D
Vasa Suppl; 1988; 23():126-9. PubMed ID: 3061035
[No Abstract] [Full Text] [Related]
31. [Experience with intravenous prostaglandin E1 in stage II b arterial occlusive disease].
Dé P; Hepp W
Vasa Suppl; 1990; 30():139-41. PubMed ID: 2075565
[No Abstract] [Full Text] [Related]
32. [Treatment of arterial diseases with trental 400. Results of a double-blind study].
Völker D
Med Welt; 1978 Aug; 29(32):1244-7. PubMed ID: 672594
[No Abstract] [Full Text] [Related]
33. Ticlopidine in the treatment of peripheral occlusive arterial disease.
Arcan JC; Panak E
Semin Thromb Hemost; 1989 Apr; 15(2):167-70. PubMed ID: 2665087
[No Abstract] [Full Text] [Related]
34. Prostanoids in therapy of peripheral arterial occlusive disease.
Creutzig A; Caspary L
Therapie; 1991; 46(3):241-5. PubMed ID: 1792658
[TBL] [Abstract][Full Text] [Related]
35. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
J Med; 1988; 19(2):89-107. PubMed ID: 3049876
[TBL] [Abstract][Full Text] [Related]
36. Testosterone and fibrinolytic activity.
Winther O
Scand J Clin Lab Invest Suppl; 1967; 99():207-10. PubMed ID: 6060734
[No Abstract] [Full Text] [Related]
37. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
Duthois S; Cailleux N; Lévesque H
J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
[TBL] [Abstract][Full Text] [Related]
38. [Double blind clinical experiences with L.S. 121 (praxilene) in patients with chronic ischemic peripheral syndromes].
Bianchi G
Minerva Chir; 1974 Aug; 29(15-16):885-90. PubMed ID: 4607675
[No Abstract] [Full Text] [Related]
39. [Therapy of arterial occlusive diseases. The effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study)].
Battke K; Buchwalsky R; Barmeyer J; Hoffmann G; Reindell H
Fortschr Med; 1978 Jul; 96(26-27):1381-6. PubMed ID: 669532
[No Abstract] [Full Text] [Related]
40. [Double-blind randomized comparative study of nicergoline naftidrofuryl on the quality of life in chronic obliterative arteriopathy of lower limbs with intermittent claudication].
Meilhac B; Montestruc F; Aubin F; Djian F; Rouffy J
Therapie; 1997; 52(3):179-86. PubMed ID: 9366101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
